CELUW

Celularity Inc

• TipRanks·04/01 01:49

  Celularity Delays Annual 10-K Filing Amid Strains

• Reuters·03/31 21:14

  Celularity delays annual report filing, cites liquidity and accounting staffing constraints

• TipRanks·03/12 12:55

  NexGel announces terms of agreement of license for products from Celularity

• Benzinga·03/12 12:53

  NEXGEL Announces Consideration Terms Of Agreement To License And Acquire Portfolio Of Commercial-Stage Regenerative Biomaterial Products From Celularity; Consideration To Include $15M Upfront Cash Payment And Addl. $20M In Milestone Payments

• Reuters·03/12 12:45

  Nexgel to pay USD 15 million upfront to acquire Celularity regenerative biomaterials portfolio

• Reuters·03/12 12:45

  NEXGEL INC - DEAL EXPECTED TO TRIPLE ANNUAL REVENUE TO $35 MLN AND MAKE COMPANY PROFITABLE UPON CLOSING

• TipRanks·03/12 12:35

  Celularity reiterates strategic commercialization partnership with NEXGEL

• NASDAQ·03/11 14:22

  NEXGEL Signs Agreement With Celularity To License And Acquire 6 Biomaterial Products; Stock Down

• TipRanks·03/10 13:35

  Celularity Licenses Biomaterials Portfolio to NexGel Partner

• TipRanks·03/10 12:51

  NexGel sign agreement to license, acquire portfolio of products from Celularity

• Seeking Alpha·03/10 12:45

  Celularity secures strategic license deal worth up to $35M for biomaterials portfolio

• Reuters·03/10 12:45

  NEXGEL INC - EXPECTS TO CLOSE $14.9 MLN IN ADDITIONAL FINANCING IN Q1 OR EARLY Q2 2026

• TipRanks·03/10 12:41

  Celularity secures $35M strategic license deal

• Benzinga·03/10 12:32

  Celularity Signs $35M Agreements For Its Placental-Derived Biomaterials Portfolio

• Benzinga·03/10 12:30

  EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue